血栓弹力图指导的肝硬化非静脉曲张性出血患者血制品输注:一项随机对照试验
本研究纳入96例存在显著凝血功能障碍(INR>1.8和/或血小板计数<50×10^9/L)且经内镜确诊为非静脉曲张性上消化道出血的肝硬化患者,随机分为血栓弹力图(TEG)指导输血组(49例)和标准治疗(SOC)组(47例)。TEG组仅26.5%的患者输注了全部三种血制品(新鲜冰冻血浆、血小板和冷沉淀),而SOC组为87.2%(P<0.001)。TEG组出血控制失败、再出血预防失败和死亡率与SOC组相似。
要点
- TEG指导输血策略较标准治疗显著减少血制品使用。
- TEG组26.5%输注全部三种血制品,SOC组为87.2%(P<0.001)。
- 两组出血控制失败、再出血预防失败和死亡率相似。
核心结论
- 在伴有凝血功能障碍和非静脉曲张性上消化道出血的晚期肝硬化患者中,TEG指导的输血策略较标准治疗(依据INR和血小板计数指导输血)显著降低血制品使用,且不增加出血控制失败、再出血预防失败和死亡率。
研究设计与样本
- 随机对照试验,纳入96例存在显著凝血功能障碍(定义为INR>1.8和/或血小板计数<50×10^9/L)且经上消化道内镜确诊为非静脉曲张性上消化道出血的肝硬化患者。
- 患者随机分配至TEG指导输血策略组(TEG组,n=49)或标准治疗组(SOC组,n=47)。
主要发现
- TEG组26.5%的患者输注了全部三种血制品(新鲜冰冻血浆、血小板和冷沉淀),而SOC组为87.2%(P<0.001)。
- TEG组7例(14.3%)患者未接受任何血制品输注,SOC组无此类患者(P=0.012)。
- TEG组新鲜冰冻血浆、血小板和冷沉淀的使用量均显著低于SOC组。
- 两组出血控制失败、再出血预防失败和死亡率相似。
关键数值与推荐
- 本研究显著凝血功能障碍定义为INR>1.8和/或血小板计数<50×10^9/L。
- TEG组输注全部三种血制品的比例为26.5%,SOC组为87.2%(P<0.001)。
- TEG组未接受任何血制品输注的比例为14.3%(7例),SOC组为0%(P=0.012)。
临床怎么用
- 对于伴有凝血功能障碍和非静脉曲张性上消化道出血的晚期肝硬化患者,TEG指导的输血策略可显著减少血制品使用,且不增加出血控制失败、再出血预防失败和死亡率。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Thromboelastography (TEG) provides a more comprehensive global coagulation assessment than routine tests (international normalized ratio [INR] and platelet [PLT] count), and its use may avoid unnecessary blood component transfusion in patients with advanced cirrhosis and significant coagulopathy who have nonvariceal upper gastrointestinal (GI) bleeding. A total of 96 patients with significant coagulopathy (defined in this study as INR >1.8 and/or PLT count < 50 × 109 /L) and nonvariceal upper GI bleed (diagnosed after doing upper gastrointestinal endoscopy, which showed ongoing bleed from a nonvariceal source) were randomly allocated to TEG-guided transfusion strategy (TEG group; n = 49) or standard-of-care (SOC) group (n = 47). In the TEG group, only 26.5% patients were transfused with all three blood components (fresh frozen plasma [FFP], PLTs, and cryoprecipitate) versus 87.2% in the SOC group (P < 0.001). Although 7 (14.3%) patients in the TEG group received no blood component transfusion, there were no such patients in the SOC group (P = 0.012). Also, there was a significantly lower use of blood components (FFP, PLTs, and cryoprecipitate) in the TEG group compared with the SOC group. Failure to control bleed, failure to prevent rebleeds, and mortality between the two groups were similar. Conclusion: In patients with advanced cirrhosis with coagulopathy and nonvariceal upper GI bleeding, TEG-guided transfusion strategy leads to a significantly lower use of blood components compared with SOC (transfusion guided by INR and PLT count), without an increase in failure to control bleed, failure to prevent rebleed, and mortality.
引用
- Kumar M, Ahmad J, Maiwall R, et al. Thromboelastography-Guided Blood Component Use in Patients With Cirrhosis With Nonvariceal Bleeding: A Randomized Controlled Trial. Hepatology. 2019. PMID: 31148204. doi:10.1002/hep.30794
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。